Biotech | May 02, 2022
Xcardia announces first-in-human use of its new Xtractor device
The announcement follows FDA 510(k) clearance of device
The announcement follows FDA 510(k) clearance of device
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Avacc 3 has significant advantages over existing whooping cough vaccines
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Subscribe To Our Newsletter & Stay Updated
